Seismic Therapeutic is a biotechnology company integrating machine learning across the entire biologics discovery process to accelerate immunology drug development. Using our IMPACT™ platform, we are addressing the central challenges of biologics discovery and development by fully integrating machine learning with the key elements of biologics drug discovery – structural biology, protein engineering and translational immunology – to create optimized therapies on an accelerated path to patients. Seismic Therapeutic has an emerging pipeline of novel biologics to address adaptive immune system dysregulation to treat autoimmune diseases. The company is backed by a strong syndicate of life sciences investors and is located in the Boston biotechnology hub.

Biotechnology

Education

Seismic Therapeutic

Jo Viney

Melanie Manning

Yi Xing

Ivan Mascanfroni

Daniela Cipolletta

Jyothsna Visweswaraiah

John Sundy

Kevin Otipoby

Edward Freedman

Maude Tessier

Debora Marks

Nathan Higginson-Scott

The leadership team at Seismic Therapeutic has experience in a variety of industries, including pharmaceuticals, biotechnology, and healthcare. They have also worked in a variety of roles, including business development, portfolio strategy, and program management. The team has a strong educational background, with degrees from some of the top schools in the world, including the MIT Sloan School of Management, Babson College, and the University of Toronto.

Leadership Team

Founding Team

Board of Directors

Leadership Team

About

Team members

Other teams at Seismic Therapeutic

Founding Team

Board of Directors